Francisco Javier C. L.
- Country
- Spain
- Department
- Pneumology
Research Overview
- Phase 3b/4 Randomized Double‑Blind Study of Depemokimab 100 mg SC Q26 weeks vs Placebo on Exacerbations and Lung‑Function Decline in Adults/Adolescents with Type 2 Asthma
- Efficacy and Safety of Depemokimab vs. Mepolizumab in Adults with Relapsing/Refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA)
- Efficacy and Safety Evaluation of Methyl-(1-{[6-{[(1S)-1-Cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)-pyrimidin-4-yl]carbonyl}piperidin-4-yl)carbamate-Mono(4-methylbenzenesulfonate) Monohydrate in Eosinophilic Granulomatosis with Polyangiitis
Data & Insights
Has run more than one trial at 32 of 135 partner sites.
Specializations
Autoimmune Disorders
This investigator specializes in treating Eosinophilic Granulomatosis with Polyangiitis (EGPA), a rare autoimmune condition affecting blood vessels. Their research encompasses both standard cases and complex presentations of the disease.
- EGPA Management
- Vasculitis Treatment
- Autoimmune Disease Therapy
Particular attention is given to developing therapeutic approaches for patients with relapsing or refractory forms of the condition.
Novel Therapeutics
The investigator focuses on evaluating emerging treatments for inflammatory disorders, with specific interest in investigating novel biological therapies for EGPA management.
- Biological Therapy Assessment
- Comparative Treatment Studies
- Long-term Disease Management
Their work includes assessment of innovative therapeutic agents against established treatments in controlled clinical settings.
Clinical Outcomes
Research interests include monitoring and evaluating treatment efficacy and safety profiles in EGPA patients under various therapeutic regimens.
- Disease Remission Analysis
- Safety Monitoring
- Standard of Care Optimization
Focus areas include achieving and maintaining disease remission while ensuring patient safety and quality of life.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.